Plunkett Research Online: Curis Inc

CURIS INC (CRIS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Curis, Inc. is a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer. The firm’s clinical stage drug candidates include: Fimepinostat, CA-4948 and CA-170. Fimepinostat, Curis’ internally-developed drug candidate is for patients.....



Curis Inc
Ticker: CRIS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 503-6500
Fax: 617 499-2927
Address: 4 Maguire Road
Lexington, MA 02421 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Regenerative Medicine
Signaling Pathway Therapeutics
ContactsDescription

James DentzerCEO/CFO/Director/President
William SteinkraussChief Accounting Officer/Vice President, Divisional
See More
Curis, Inc. is a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer. The firm’s clinical stage drug candidates include: Fimepinostat, CA-4948 and CA-170. Fimepinostat, Curis’ internally-developed drug candidate is for patients.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Wilmer Cutler Pickering Hale and Dorr LLP
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Fimepinostat (CUDC-907)
CA-4948
CA-170
CI-8993
CA-327
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

Curis offers its employees comprehensive benefits.